High-resolution metagenomic characterization of gut microbiota composition and functional pathways in irritable bowel syndromeOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
Researchers examined gut microbiota composition and functional pathways in women with moderate to severe irritable bowel syndrome (IBS), comparing them to healthy controls. The goal was to identify microbial taxa and metabolic pathways linked to gut-brain axis dysfunction in IBS.
How was it studied?
The team performed whole metagenome shotgun sequencing on stool samples from 63 female IBS patients and 34 female healthy controls. Microbial composition and functional pathways were compared using differential abundance analysis and functional profiling against the MetaCyc database.
What did they find?
Microbial richness and diversity were only slightly reduced in IBS, with high variability and no robust separation from controls. Streptococcus sp. and the sulfate-reducing bacterium Desulfovibrio piger were enriched in IBS, while Bifidobacterium and Methanobrevibacter were reduced. Functional profiling identified 39 differentially abundant pathways: amino acid biosynthesis pathways (L-isoleucine, L-threonine) were more prominent in IBS, while carbohydrate degradation pathways (galactose, stachyose) were enriched in controls.
Why it matters
These modest but significant compositional and functional shifts may contribute to IBS symptoms, though high intra-group variability highlights the complexity of the disorder. The authors call for larger, multi-omics studies to define robust microbial markers of IBS.